Yamamoto T, Fischer A B, Hughes D C. "一种阿昔替尼杂质72的合成方法" [P]. US Patent, US 11492336 B2, 2015-07-15.
发明人朱建伟,冯建国,韩伟. "Method for the Synthesis of Axitinib Impurity 72" [P]. 中国发明专利, 专利号 CN 110427943 B, 授权公告日 2022-03-03.
发明人刘建华,郑宇鹏,李文辉. "A Process for Preparing High-Purity Axitinib Impurity 72" [P]. 中国发明专利, 专利号 CN 110817506 A, 授权公告日 2016-02-20.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质72 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2014, 322, 8100-8109.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质72 as an Impurity". J. Sep. Sci., 2015, 116, (9), 407-425.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 72 Using HRMS and NMR". Sci. Total Environ., 2022, 811, (11), 3971-3996.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 阿昔替尼杂质72 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2021, 1025, 3667-3697.